Loratadine
Cardinal Health 107, Llc
Human Otc Drug
NDC 55154-4976Loratadine is a human otc drug labeled by 'Cardinal Health 107, Llc'. National Drug Code (NDC) number for Loratadine is 55154-4976. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Loratadine drug includes Loratadine - 10 mg/1 . The currest status of Loratadine drug is Active.
Drug Information:
| Drug NDC: | 55154-4976 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Loratadine |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Loratadine |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Cardinal Health 107, Llc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Tablet |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | LORATADINE - 10 mg/1
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | ORAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 14 Jun, 2013 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 10 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Cardinal Health 107, LLC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 311372
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| UPC: | 0055154497602
|
| UPC stands for Universal Product Code. |
| UNII: | 7AJO3BO7QN
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 55154-4976-0 | 10 BLISTER PACK in 1 BAG (55154-4976-0) / 1 TABLET in 1 BLISTER PACK | 14 Jun, 2013 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose antihistamine
Product Elements:
Loratadine loratadine loratadine loratadine starch, corn lactose monohydrate magnesium stearate rx526
Indications and Usage:
Uses non-drowsy* 24 hour *when taken as directed. see drug facts panel. indoor and outdoor allergies temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: · itching of the nose or throat · runny nose · itchy, watery eyes · sneezing
Warnings:
Warnings do not use if you have ever had an allergic reaction to this product or any of its ingredients. this package is intended for institutional use only. this unit-dose package is not child-resistant. if dispensed for outpatient use, a child-resistant container should be utilized.
When Using:
When using this product do not take more than directed. taking more than directed may cause drowsiness.
Dosage and Administration:
Directions adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor for your protection: do not use if blister is torn or broken.
Stop Use:
Stop use and ask a doctor if an allergic reaction to this product occurs. seek medical help right away.
Package Label Principal Display Panel:
Principal display panel non-drowsy* 24 hour allergy relief loratadine tablets, usp 10 mg antihistamine 10 tablets bag label
Further Questions:
Questions? questions? for ranbaxy/ohm laboratories call 1-800-406-7984 the drug product contained in this package is from ndc#51660-526, ohm laboratories inc. packaged and distributed by: american health packaging columbus, ohio 43217 americanhealthpackaging.com an amerisourcebergen company american health packaging is a trademark owned by its respective owner. distributed by: cardinal health dublin, oh 43017 l4955647-10818 l4955647-20818